Retraction to: Leukemia
The authors have decided to retract this article  because after publication they discovered that the SKM1-R, OCI-AML2 and MOLM13 cell lines used were cross-contaminated with murine hematopoietic cells. The results obtained using these cell lines are therefore unreliable. The data presented on primary patient samples remains valid.
All authors agree with this retraction.
Dubois A, Furstoss N, Calleja A, Zerhouni M, Cluzeau T, Savy C et al. LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia. 2019;33:1501–13.
The original article can be found online at https://doi.org/10.1038/s41375-018-0336-1.
About this article
Cite this article
Dubois, A., Furstoss, N., Calleja, A. et al. Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia (2020). https://doi.org/10.1038/s41375-020-0969-8